It also interferes with STAT3, PI3K/AKT, and Wnt/β-catenin signaling, contributing to cell cycle arrest and tumor suppression in lung, ovarian, and prostate cancers (71–73). The gene discussed is AKT1; the disease is prostate carcinoma.